- Home
- OVLY vs CNTX Comparison
OVLY vs CNTX Comparison
Compare OVLY & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OVLY | CNTX |
|---|---|---|
| Founded | 1990 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 291.4M | 283.9M |
| IPO Year | 2008 | 2021 |
Fundamental Metrics
Financial Performance| Metric | OVLY | CNTX |
|---|---|---|
| Price | $33.59 | $0.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $6.60 |
| AVG Volume (30 Days) | 68.4K | ★ 1.6M |
| Earning Date | 04-22-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.27% | N/A |
| EPS Growth | N/A | ★ 17.39 |
| EPS | ★ 0.64 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $52.61 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $25.25 | $0.56 |
| 52 Week High | $35.97 | $3.62 |
Technical Indicators
Market Signals| Indicator | OVLY | CNTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.21 | 17.88 |
| Support Level | $32.07 | N/A |
| Resistance Level | $33.82 | $0.98 |
| Average True Range (ATR) | 1.11 | 0.23 |
| MACD | 0.03 | -0.17 |
| Stochastic Oscillator | 40.18 | 0.91 |
Price Performance
Historical ComparisonAbout OVLY Oak Valley Bancorp (CA)
Oak Valley Bancorp is a bank holding company that operates through Oak Valley Community Bank (the Bank). The Bank offers a complement of business checking and savings accounts for its business customers. The Bank also offers commercial and real estate loans, as well as lines of credit. In addition, the bank provides other services for both individuals and businesses including online banking, remote deposit capture, mobile banking, merchant services, night depository, extended hours, wire transfer of funds, note collection, and automated teller machines in a national network. Its primary source of revenue is net interest income.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.